RainDance Technologies, Inc., a provider of innovative droplet-based microfluidic solutions for human health and disease research, will dedicate its new headquarters and commercial and manufacturing operations on Friday, Sept. 26th in Lexington, Mass. at 3:00 p.m.
RainDance's 28,000-square-foot building in Lexington will more than double its former space in Guilford, Conn. RainDance plans to increase its workforce by some 50 percent -- adding new biologists and chemists, mechanical engineers and technicians, software programmers, customer service representatives, and administrative support -- and will employ nearly 100 within the year.
Company officials made the decision to relocate to Massachusetts based on Governor Deval Patrick's Life Sciences Initiative.
RainDance will also announce a collaboration with a major pharmaceutical company to develop a new droplet-based methodology for the drug discovery process.
RainDance's new RainStorm(TM) droplet-based microfluidic technology has broad use in the prediction and prevention of human disease. The simplicity, speed, and capabilities of the technology will enable researchers to design experiments in ways previously unaffordable or unimaginable. RainStorm technology will find numerous uses in biomedical applications, including genomics research, gene expression analysis, compound screening, and biomarker detection.
RainDance was founded by scientists from Harvard University, the Medical Research Centre in Cambridge, England, and the ESPCI in Paris, and the company's scientific advisers include three Nobel Prize winners plus a pioneer in protein engineering who has been knighted for services to molecular biology.
CONTACT: Don Goncalves, +1-781-793-9380, dgoncalves@tizinc.com, or Cortney
Lusignan, +1-781-793-9380, clusignan@tizinc.com, both for RainDance
Technologies, Inc.
